基本信息
浏览量:0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Since I began my career in academic psychiatry, I have been actively involved in research, teaching and university service within the Department of Neuropsychiatry at the Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez (INNN). During my early years at the INNN I established both First-Episode Psychosis (FEP) and The Adolescent Study of Neuropsychiatric Assessment and Imaging (PIENSA) Outpatient Research Programs. I also coordinate the evaluation and treatment of antipsychotic-naïve FEP individuals in the inpatient Neuropsychiatry Department. Early psychosis patients at the INNN are assessed with functional neuroimaging, electrophysiology, neurocognition, and genetics, before and after antipsychotic treatment. Medical students, residents and postgraduate students who are interested in this area of investigation become part of the research team and actively participate in research. To the best of my knowledge, this is the only facility in Mexico with such a program that recruits these valuable clinical populations.
Because of my work in this important area of investigation, I have been able to establish collaborations both nationally, with several Mexican academic institutions, and internationally with the University of California, San Diego, Cornell University and Columbia University, New York, and the Centre for Addiction and Mental Health, Toronto. I have received funding as a Principal Investigator to study potential disease biomarkers such as glutamate and GABA measured by Magnetic Resonance Spectroscopy (CONACyT), and the effect of different treatment modalities such as antipsychotic medication and Transcranial Magnetic Stimulation (Mexico City Institute for Science and Technology - ICyTDF). I am the Co-Principal Investigator on an R21 through the Fogarty Institute and the NIMH to study inflammatory biomarkers in early psychosis, co-investigator on an R34 through the NIMH to study compensatory cognitive training in clinical high risk youth, and co-investigator on an R01 to study biomarkers of conversion risk and treatment response in early-stage Schizophrenia. Since 2009, I have received support through the CONACyT’s National System of Investigators (SNI).
研究兴趣
论文共 134 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Kenneth Wengler,Seth C. Baker, Anastasia Velikovskaya, Alissa Fogelson,Ragy R. Girgis,Francisco Reyes-Madrigal,Seonjoo Lee,Camilo de la Fuente-sandoval,Najate Ojeil,Guillermo Horga
JAMA PSYCHIATRYno. 2 (2024): 198-208
Kenneth Wengler,Seth Baker, Anastasia Velikovskaya, Alissa Fogelson,Ragy Girgis,Francisco Reyes-Madrigal,Seonjoo Lee,Camilo de la Fuente-Sandoval,Najate Ojeil,Guillermo Horga
NEUROPSYCHOPHARMACOLOGY (2023): 376-376
引用0浏览0引用
0
0
Brain, behavior, and immunity (2023): 270-276
加载更多
作者统计
#Papers: 130
#Citation: 3617
H-Index: 31
G-Index: 59
Sociability: 7
Diversity: 3
Activity: 55
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn